Streetbeat News

Analyst Ratings

COGT

Needham analyst Ami Fadia has reiterated a Buy rating on Cogent Biosciences (NASDAQ:COGT) and maintained a $22 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:42 am

LZM

Roth MKM analyst Mike Niehuser has initiated coverage on Lifezone Metals (NYSE:LZM) with a Buy rating and set a price target of $14 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:39 am

FL

Citigroup analyst Paul Lejuez has downgraded Foot Locker (NYSE:FL) from Neutral to Sell and set a new price target of $18.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:36 am

CNI

Deutsche Bank analyst Amit Mehrotra has downgraded Canadian National Railway (CNI) from Buy to Hold and reduced the price target from $125 to $121.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:28 am

PCH

Raymond James analyst Buck Horne has downgraded PotlatchDeltic (NASDAQ:PCH) from Strong Buy to Market Perform, indicating a change in the firm's outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:25 am

WY

Raymond James analyst Buck Horne has downgraded Weyerhaeuser (NYSE:WY) from Strong Buy to Market Perform, indicating a change in the firm's outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:23 am

ODFL

Deutsche Bank analyst Amit Mehrotra has downgraded Old Dominion Freight Line (ODFL) from Buy to Hold and reduced the price target from $475 to $386.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:22 am

JAZZ

UBS analyst Ashwani Verma downgraded Jazz Pharmaceuticals (NASDAQ:JAZZ) from Buy to Neutral and reduced the price target from $170 to $135.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:12 am

CP

Deutsche Bank analyst Amit Mehrotra downgraded Canadian Pacific Kansas (NYSE:CP) from Buy to Hold and reduced the price target from $85 to $77.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:07 am

AFYA

JP Morgan analyst Marcelo Santos has downgraded Afya (NASDAQ:AFYA) from Overweight to Neutral while increasing the price target from $22 to $23.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:05 am